AVIR Stock Price
Atea Pharmaceuticals, Inc.
AVIR stock price is $4.63 (-7.03% on the day), giving Atea Pharmaceuticals, Inc. a market cap of $371.35M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
AVIR Stock Overview
- Price
- $4.63
- Previous close
- $4.98
- Open
- $4.92
- Market cap
- $371.35M
- P/E ratio
- -2.3
- 52-week range
- $2.87 - $6.45
- 1-year price target
- $8.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 38
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVIR | $4.63 | -7.0% | 414.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atea Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW